mir stock: Mirion Technologies (MIR)

A comprehensive investor-focused profile of mir stock (Mirion Technologies, Inc., NYSE: MIR), covering company background, listing details, business segments, financial snapshot, stock performance,...

2024-07-11 06:05:00

By Emma Shah

Article rating

4.5

118 ratings

Bitget offers a variety of ways to buy or sell popular cryptocurrencies. Buy now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MIR (Mirion Technologies, Inc.) — stock profile

mir stock refers to Mirion Technologies, Inc. traded on the New York Stock Exchange under the ticker MIR. This profile summarizes what investors and interested readers should know about the company and its stock: company overview, listing and ticker details, business segments, financial and market metrics, analyst coverage and recent news, ownership and liquidity, risks and governance, and pointers to reliable investor resources. Readers will get a clear, neutral snapshot of mir stock and where to find up‑to‑date market data and official filings.

Company overview

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions. The company designs and supplies equipment, software and services that support radiation safety, diagnostic and therapeutic medical imaging, nuclear power plant operations, defense and research applications. Its products include radiation detectors, monitoring systems, imaging devices, calibration sources, shielding solutions and a range of radiation services such as installation, maintenance and training.

Primary end markets include the medical sector (hospitals, imaging centers, therapeutic oncology), nuclear and safety (commercial nuclear power plants, decommissioning, government and defense), and research and industrial customers. Mirion is headquartered in [Headquarters — verify with company filings], with founding and corporate history discussed below. Senior leadership typically includes a Chief Executive Officer, Chief Financial Officer and heads of major business units; readers should consult the company’s investor relations page and SEC filings for the current executive roster.

Ticker and listing details

Ticker symbol: MIR (common stock). Exchange: New York Stock Exchange (NYSE). Trading currency: US dollar (USD). Share class: common stock (Class A common stock where applicable — consult the company’s articles of incorporation and recent filings for share class specifics). Standard US equity trading hours apply (regular session, pre‑market and after‑hours trading according to exchange rules). Settlement follows standard US equity settlement conventions (T+1/T+2 depending on the market and regulatory changes; verify current settlement cycle with your broker).

Business segments and operations

Mirion traditionally reports and operates across major segments aligned with end markets. Common segment groupings include:

Medical: Diagnostic imaging, radiation therapy, nuclear medicine instrumentation, dosimetry solutions and related software and services for hospitals, clinics and imaging centers.
Nuclear & Safety: Radiation monitoring and detection systems, instrumentation for nuclear power plants, decommissioning services, environmental monitoring and defense/government solutions.

Key revenue drivers are capital equipment sales in medical imaging and nuclear measurement, recurring service contracts (installation, calibration, maintenance), consumables such as calibration sources and detectors, and software/analytics offerings. Demand drivers vary by segment: medical capital expenditure cycles and healthcare budgets affect the medical segment, while nuclear industry project cycles, government defense spending and regulatory-driven upgrades influence nuclear & safety demand.

Corporate history and major milestones

Mirion’s corporate history includes origins from legacy businesses in radiation detection and nuclear measurement. Over time the company has grown via product development and acquisitions to broaden its technology portfolio and geographic reach. Notable corporate milestones that are typically relevant for investors include:

Founding and early product milestones (see company historical disclosures).
Major acquisitions and integrations that expanded imaging, dosimetry, monitoring and services capabilities.
Public listing events or material capital markets transactions — the company’s NYSE listing date and listing history should be confirmed in SEC filings and press releases.
Investor day presentations, strategic reviews, and significant refinancing or convertible note issuances when applicable.

For precise dates and transaction values, consult Mirion’s press releases and SEC filings; those primary sources provide authoritative timelines and valuation details.

Key financial metrics

This section summarizes the kinds of financial metrics investors commonly track for mir stock. Numbers change over time; always check the latest quarterly reports and SEC filings for up‑to‑date figures.

Revenue (trailing): Revenue profiles reflect the mix of capital product sales and recurring services. Quarterly and trailing‑twelve‑month (TTM) revenue are reported in earnings releases.
Profitability: Net income and EPS trends vary with product cycles and integration costs for acquisitions. Investors monitor gross margin (product mix), operating margin (scale and cost control) and diluted EPS.
Cash flow: Operating cash flow and free cash flow (operating cash less capital expenditures) indicate the company’s ability to fund operations, service debt and invest in R&D.
Leverage: Debt levels and leverage ratios such as net debt/EBITDA are key for capital‑intensive specialty industrial businesses. Convertible notes or other hybrid instruments can affect dilution and capital structure.
Valuation ratios: Common market multiples include price/earnings (P/E), price/sales (P/S), and price/book (P/B). Such ratios must be calculated using current market price and the most recent reporting period figures.

Note: This profile intentionally avoids publishing specific stale numeric values. For quantifiable metrics (market cap, P/E, debt balance, EPS, revenue), use the company’s latest 10‑Q/10‑K and market data providers. See the Investor relations and public disclosures section below for authoritative sources.

Stock performance and historical price

mir stock performance is influenced by company fundamentals, industry cycles (medical device spending and nuclear power projects), M&A activity, and broader market sentiment toward industrial and technology stocks that serve regulated markets.

Performance perspectives investors commonly examine:

Intraday and short term (1M): Price can move on news flow (earnings releases, guidance changes, analyst notes).
Medium term (6M–1Y): Tracks earnings trends, backlog and major contract awards or product rollouts.
Long term (3–5Y+): Reflects structural trends in medical imaging adoption, nuclear investment cycles, and the success of integration of acquisitions.
52‑week range: A commonly reported metric showing the low and high over the past year; check market quote pages for the current 52‑week range.

Market movements in mir stock may correlate with sector dynamics (e.g., renewed interest in nuclear power projects, large government contracts, or healthcare capital spending), and can also be sensitive to analyst coverage and macro risk appetite.

Historical price highlights

Periods of material appreciation are often linked to positive earnings surprises, large contract wins, or strategic acquisitions that expand addressable markets.
Volatility frequently spikes around quarterly earnings releases, major regulatory announcements, or when management provides materially updated guidance.
Notable analyst actions and changes in price targets can also produce temporary trading volume and price moves.

Ownership, float, and liquidity

Key ownership and liquidity characteristics investors examine for mir stock include shares outstanding, public float, average daily trading volume, and concentration of holdings among institutional investors and insiders.

Shares outstanding & float: Official counts are available in company filings and on market data pages. Float (publicly tradable shares) may be lower where founders, strategic investors or restricted shares represent a material portion of total shares outstanding.
Average daily volume: Volume trends inform liquidity — higher average daily volume typically enables tighter spreads and easier trade execution, while low volume can increase volatility and execution costs.
Institutional ownership: Major institutional holders (mutual funds, pensions, asset managers) can influence liquidity and stability; changes in institutional ownership can affect price discovery.
Insider transactions: Executive or board member purchases/sales are disclosed in filings; substantial insider selling may be interpreted by some investors as a signal, while opportunistic buying can be viewed differently.

For current ownership tables and up‑to‑date volume statistics, consult the latest SEC filings (Forms 10‑K, 10‑Q, 13D/G) and market data providers.

Analyst coverage and market sentiment

Analyst coverage provides one lens into market sentiment for mir stock. As of January 23, 2026, several analysts maintain published views on Mirion. Specifically:

As of January 23, 2026, according to Benzinga, Morgan Stanley analyst Christopher Snyder initiated coverage on Mirion Technologies, Inc. (NYSE: MIR) with an Equal‑Weight rating and announced a price target of $29. Mirion Technologies shares closed at $26.69 on Thursday, according to the same report.

Analyst ratings typically fall across a spectrum (Buy/Overweight, Hold/Equal‑Weight, Sell/Underweight). Where available, consensus price targets and rating distributions (percentage of Buy/Hold/Sell recommendations) help provide context on market expectations. Option market signals (implied volatility and put/call skew) and short interest data are additional inputs investors use to gauge sentiment and risk‑perception, with option‑market implied volatility tending to rise around expected catalysts (earnings, regulatory decisions).

Investors should note that analyst views change over time: upgrades, downgrades and price target revisions often appear around earnings or material corporate events. For a complete and contemporaneous view of analyst rating changes, consult live analyst tracking pages and brokerage research notes.

Recent corporate actions and news (examples)

Recent corporate activity that commonly affects mir stock includes quarterly earnings announcements, investor presentations, debt refinancing, acquisitions and completed integrations, and regulatory or contract news. Examples of items that may be classified as material:

Quarterly results that beat or miss consensus expectations — impacts short‑term price moves.
Acquisitions that expand product offerings, geographic reach, or customer penetration — may be accretive or dilutive depending on pricing and integration costs.
Refinancing of debt or issuance of convertible securities — affects leverage and potential dilution.
Large contract awards (nuclear site work, multi‑year service agreements with healthcare systems) — support revenue visibility.
Regulatory approvals or compliance actions affecting product deployment in clinical settings.

Because corporate actions change frequently, check the company’s press release archive and SEC filings for material updates. For example, analyst initiation reported by Benzinga (dated January 23, 2026) is a recent data point that may influence short‑term sentiment.

Risks and considerations for investors

Investors evaluating mir stock should be aware of several risk categories:

Regulatory risk: The medical and nuclear sectors are highly regulated. Changes in health regulations, device approvals, or nuclear safety standards can affect product adoption and time‑to‑market.
Market cyclicality: Capital spending cycles in healthcare and nuclear projects can be lumpy; revenue and margin profiles may reflect these cycles.
Integration and M&A risk: Acquisitions intended to broaden capabilities carry integration risks and potential short‑term cost impacts.
Leverage and financing: Elevated debt levels or hybrid securities can create refinancing risk or potential dilution if convertible instruments convert into equity.
Technology and competition: Competition from other instrumentation and diagnostics providers, plus the need to invest in R&D, may compress margins if not managed effectively.

This summary is for informational purposes only; it is not investment advice. Investors should perform their own due diligence, consult primary filings, and consider speaking with a licensed financial advisor before making investment decisions.

Corporate governance and management

Governance factors that influence investor perception include board composition, executive experience, compensation practices, and governance policies (audit, risk oversight, and shareholder rights). Investors review proxy statements (DEF 14A) to evaluate director qualifications, executive compensation structure, related party transactions, and any governance proposals put to shareholders.

Leadership stability — including tenure of the CEO and key executives — and the board’s track record on capital allocation, M&A oversight and shareholder alignment can materially affect investor confidence in mir stock.

Investor relations and public disclosures

Primary sources for authoritative information on mir stock include:

The company’s investor relations site and press release archive — for earnings releases, investor presentations, and corporate announcements.
SEC filings (Forms 10‑Q, 10‑K, 8‑K, and proxy statements) — for audited financials, risk disclosures and insider transactions.
Market data providers (stock quote pages) for real‑time price, 52‑week range, market capitalization and volume statistics.

Investors who trade or monitor mir stock can use platforms such as Bitget for market access and execution. Bitget provides equity trading and market data features suitable for tracking live quotes; for custody and Web3 wallet needs, consider Bitget Wallet where applicable. Always verify order types, fees and compliance details on Bitget before trading.

References and further reading

This profile is based on company disclosures and major financial information sources. For the most current figures and event dates, consult primary sources:

Mirion investor relations and press releases (official company announcements).
SEC filings (Form 10‑K, 10‑Q, 8‑K, and proxy statements) for audited financials and governance disclosures.
Market news coverage (e.g., Benzinga reporting and analyst updates). As of January 23, 2026, Benzinga reported Morgan Stanley initiated coverage of Mirion with an Equal‑Weight rating and a $29 price target, and that Mirion closed at $26.69 on the referenced trading day.
Common financial data providers for quotes and historical data: Yahoo Finance, Reuters, MSN Money, MarketXLS (use these services directly for up‑to‑date numeric values).

Notes / disambiguation

In this article, MIR and mir stock refer specifically to Mirion Technologies, Inc., the NYSE‑listed company providing radiation detection and monitoring solutions. Other unrelated uses of the acronym or token name "MIR" (including cryptocurrency tokens or protocols that have historically used similar names) are outside the scope of this profile and should be addressed on a disambiguation page if needed.

How to stay up to date

To keep track of mir stock developments:

Subscribe to Mirion’s investor relations email alerts and press releases.
Monitor SEC filings for official quarterly and annual reports.
Follow reputable financial news services and analyst reports for earnings previews and rating changes. For the latest analyst rating changes (including initiations, upgrades and downgrades), refer to dedicated analyst‑tracking pages on market news platforms.
Use Bitget for market access and monitoring — check Bitget’s tools for live quotes, order execution, and wallet custody options.

Final notes and next steps

mir stock is a specialty industrial/medical instrumentation equity that reacts to a mix of product cycles, regulatory developments and corporate actions. This article provides a structured guide to the company and stock; for trading or portfolio decisions, consult live market data and primary filings. Explore more about trading and market data on Bitget to monitor mir stock in real time and access investor resources.

This profile is informational and neutral in tone. It is not investment advice. For precise numeric values (market cap, outstanding shares, debt balances, EPS and real‑time price), use the company’s filings and up‑to‑date market data providers.

The content above has been sourced from the internet and generated using AI. For high-quality content, please visit Bitget Academy.